Charles Schwab
UNH icon

Charles Schwab’s UnitedHealth UNH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.34B Buy
7,502,469
+432,084
+6% +$135M 0.4% 44
2025
Q1
$3.7B Buy
7,070,385
+847,054
+14% +$444M 0.69% 33
2024
Q4
$3.15B Buy
6,223,331
+182,361
+3% +$92.2M 0.58% 34
2024
Q3
$3.53B Sell
6,040,970
-458,840
-7% -$268M 0.67% 31
2024
Q2
$3.31B Buy
6,499,810
+120,777
+2% +$61.5M 0.63% 31
2024
Q1
$3.13B Buy
6,379,033
+394,180
+7% +$194M 0.72% 23
2023
Q4
$3.14B Buy
5,984,853
+141,646
+2% +$74.4M 0.8% 21
2023
Q3
$2.94B Buy
5,843,207
+27,127
+0.5% +$13.6M 0.84% 22
2023
Q2
$2.78B Buy
5,816,080
+34,491
+0.6% +$16.5M 0.79% 24
2023
Q1
$2.72B Buy
5,781,589
+441,733
+8% +$208M 0.83% 23
2022
Q4
$2.83B Buy
5,339,856
+126,075
+2% +$66.8M 0.91% 17
2022
Q3
$2.63B Buy
5,213,781
+35,276
+0.7% +$17.8M 0.94% 15
2022
Q2
$2.66B Buy
5,178,505
+31,137
+0.6% +$16M 0.93% 14
2022
Q1
$2.63B Buy
5,147,368
+132,461
+3% +$67.6M 0.79% 18
2021
Q4
$2.52B Buy
5,014,907
+63,192
+1% +$31.7M 0.74% 19
2021
Q3
$1.93B Buy
4,951,715
+80,565
+2% +$31.5M 0.63% 24
2021
Q2
$1.95B Buy
4,871,150
+86,346
+2% +$34.6M 0.65% 24
2021
Q1
$1.78B Sell
4,784,804
-96,306
-2% -$35.8M 0.65% 20
2020
Q4
$1.71B Sell
4,881,110
-12,552
-0.3% -$4.4M 0.68% 17
2020
Q3
$1.53B Buy
4,893,662
+99,425
+2% +$31M 0.7% 17
2020
Q2
$1.41B Buy
4,794,237
+39,532
+0.8% +$11.7M 0.69% 18
2020
Q1
$1.19B Buy
4,754,705
+76,284
+2% +$19M 0.7% 21
2019
Q4
$1.38B Buy
4,678,421
+118,843
+3% +$34.9M 0.74% 20
2019
Q3
$991M Buy
4,559,578
+120,231
+3% +$26.1M 0.58% 27
2019
Q2
$1.08B Sell
4,439,347
-29,505
-0.7% -$7.2M 0.66% 24
2019
Q1
$1.1B Buy
4,468,852
+227,173
+5% +$56.2M 0.71% 20
2018
Q4
$1.06B Buy
4,241,679
+81,643
+2% +$20.3M 0.81% 16
2018
Q3
$1.11B Buy
4,160,036
+140,151
+3% +$37.3M 0.74% 17
2018
Q2
$986M Buy
4,019,885
+108,052
+3% +$26.5M 0.72% 18
2018
Q1
$837M Buy
3,911,833
+49,824
+1% +$10.7M 0.65% 23
2017
Q4
$851M Buy
3,862,009
+109,375
+3% +$24.1M 0.68% 25
2017
Q3
$735M Buy
3,752,634
+95,659
+3% +$18.7M 0.64% 25
2017
Q2
$678M Buy
3,656,975
+183,401
+5% +$34M 0.64% 27
2017
Q1
$570M Buy
3,473,574
+115,594
+3% +$19M 0.57% 30
2016
Q4
$537M Buy
3,357,980
+209,435
+7% +$33.5M 0.59% 28
2016
Q3
$441M Buy
3,148,545
+94,807
+3% +$13.3M 0.52% 35
2016
Q2
$431M Buy
3,053,738
+89,288
+3% +$12.6M 0.54% 34
2016
Q1
$382M Buy
2,964,450
+139,334
+5% +$18M 0.5% 38
2015
Q4
$332M Buy
2,825,116
+88,802
+3% +$10.4M 0.45% 39
2015
Q3
$317M Buy
2,736,314
+8,652
+0.3% +$1M 0.47% 35
2015
Q2
$333M Buy
2,727,662
+37,690
+1% +$4.6M 0.46% 37
2015
Q1
$318M Buy
2,689,972
+108,852
+4% +$12.9M 0.45% 37
2014
Q4
$261M Buy
2,581,120
+56,617
+2% +$5.72M 0.39% 47
2014
Q3
$218M Buy
2,524,503
+67,173
+3% +$5.79M 0.36% 49
2014
Q2
$201M Sell
2,457,330
-31,679
-1% -$2.59M 0.34% 55
2014
Q1
$204M Buy
2,489,009
+175,194
+8% +$14.4M 0.37% 50
2013
Q4
$174M Sell
2,313,815
-10,759
-0.5% -$810K 0.33% 56
2013
Q3
$169M Buy
2,324,574
+18,914
+0.8% +$1.37M 0.34% 51
2013
Q2
$151M Buy
+2,305,660
New +$151M 0.34% 57